Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
6.21
-0.06 (-0.96%)
Mar 20, 2026, 12:54 PM EDT - Market open
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.62 billion as of March 20, 2026. Its market cap has decreased by -56.63% in one year.
Market Cap
1.62B
Enterprise Value
9.85B
1-Year Change
-56.63%
Ranking
Category
Stock Price
$6.21
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.62B, a decrease of -80.79%. That is a compound annual growth rate of -28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 1.63B | -12.44% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 171.59B |
| Pfizer | 156.09B |
| Bristol-Myers Squibb Company | 121.60B |
| GSK plc | 108.68B |
| Sanofi | 107.46B |
| Biogen | 27.19B |
| Grifols | 1.69B |
| Amarin Corporation | 322.88M |